Becker and Associates has launched NexGenerix©
the only one-stop source for business critical information
on 79 new chemical entities set to become generics between
2016 to 2026.

NexGenerix© provides precise information on patent expiry, patent expiry extensions, special protection certificate, first market authorization, market authorizations, orphan and pediatric drug exclusivity and much more in 34 countries around the world.

NexGenerix© is freely available for FGD Subscribers.